Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Jordan

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Future Oncology (London, England)|November 14, 2017
Neurokinin 1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitantBernardo L Rapoport, Karin Jordan, Cindy Weinstein
European Journal of Cancer (Oxford, England : 1990)|January 22, 2005
Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatmentKarin Jordan, Christoph Kasper, Hans-Joachim Schmoll
The Oncologist|October 5, 2007
Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendationsKarin Jordan, Christoph Sippel, Hans-Joachim Schmoll
Innere Medizin (Heidelberg, Germany)|June 19, 2025
[New targeted treatment for tumor-associated cachexia : A breakthrough?]Andreas Neubauer, Camilla Leithold, Sirka Nitschmann, et al.
Muscle & Nerve|December 3, 2005
Successful treatment of MuSK antibody-positive myasthenia gravis with rituximabBerit Hain, Karin Jordan, Marcus Deschauer, et al.
Critical Reviews in Oncology/Hematology|January 9, 2007
Comparative activity of antiemetic drugsKarin Jordan, Hans J Schmoll, Matti S Aapro
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 24, 2016
Efficacy benefit of an NK1 receptor antagonist (NK1RA) in patients receiving carboplatin: supportive evidence with NEPA (a fixed combination of the NK1 RA, netupitant, and palonosetron) and aprepitant regimensKarin Jordan, Richard Gralla, Giada Rizzi, et al.
European Journal of Pharmacology|October 26, 2013
International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practiceKarin Jordan, Richard Gralla, Franziska Jahn, et al.
Muscle & Nerve|April 25, 2019
Successful use of an immune checkpoint inhibitor in a patient with myasthenia gravis in remissionBerit Jordan, Stephan Zierz, Thomas Weber, et al.
Breast Care (Basel, Switzerland)|December 5, 2019
Prevention and Management of Chemotherapy-Induced PolyneuropathyBerit Jordan, Franziska Jahn, Sandra Sauer, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Future Oncology (London, England)|November 14, 2017
Neurokinin 1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitantBernardo L Rapoport, Karin Jordan, Cindy Weinstein
European Journal of Cancer (Oxford, England : 1990)|January 22, 2005
Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatmentKarin Jordan, Christoph Kasper, Hans-Joachim Schmoll
The Oncologist|October 5, 2007
Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendationsKarin Jordan, Christoph Sippel, Hans-Joachim Schmoll
Innere Medizin (Heidelberg, Germany)|June 19, 2025
[New targeted treatment for tumor-associated cachexia : A breakthrough?]Andreas Neubauer, Camilla Leithold, Sirka Nitschmann, et al.
Muscle & Nerve|December 3, 2005
Successful treatment of MuSK antibody-positive myasthenia gravis with rituximabBerit Hain, Karin Jordan, Marcus Deschauer, et al.
Critical Reviews in Oncology/Hematology|January 9, 2007
Comparative activity of antiemetic drugsKarin Jordan, Hans J Schmoll, Matti S Aapro
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 24, 2016
Efficacy benefit of an NK1 receptor antagonist (NK1RA) in patients receiving carboplatin: supportive evidence with NEPA (a fixed combination of the NK1 RA, netupitant, and palonosetron) and aprepitant regimensKarin Jordan, Richard Gralla, Giada Rizzi, et al.
European Journal of Pharmacology|October 26, 2013
International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practiceKarin Jordan, Richard Gralla, Franziska Jahn, et al.
Muscle & Nerve|April 25, 2019
Successful use of an immune checkpoint inhibitor in a patient with myasthenia gravis in remissionBerit Jordan, Stephan Zierz, Thomas Weber, et al.
Breast Care (Basel, Switzerland)|December 5, 2019
Prevention and Management of Chemotherapy-Induced PolyneuropathyBerit Jordan, Franziska Jahn, Sandra Sauer, et al.
Pageof 11